In the past, osteomyelitis was frequent and characterized by a prolonged course, treatment response uncertainty, and occasional disfigurement. Today, the disease is less common; it is believed that the decline in prevalence may be attributed to increased availability of antibiotics and improvement of overall health patterns. Currently, more common osteomyelitis variants are seen, namely, osteoradionecrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ). Osteomyelitis, ORN, and BRONJ can present with similar symptoms, signs, and radiographic findings. However, each condition is a separate entity, with different treatment approaches. Thus, accurate diagnosis is essential for adequate management and improved patient prognosis. The aim of this paper is to report three cases of inflammatory lesions of the jaws-osteomyelitis, ORN, and BRONJ-and to discuss their etiology, clinical aspects, radiographic findings, histopathological features, treatment options, and preventive measures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814104PMC
http://dx.doi.org/10.1155/2013/402096DOI Listing

Publication Analysis

Top Keywords

bisphosphonate-related osteonecrosis
8
report three
8
three cases
8
radiographic findings
8
clinical management
4
management suppurative
4
osteomyelitis
4
suppurative osteomyelitis
4
osteomyelitis bisphosphonate-related
4
osteonecrosis osteoradionecrosis
4

Similar Publications

Local Single-Dose Teriparatide Administration for BRONJ Prevention: Insights from a Rat Model Study.

J Maxillofac Oral Surg

December 2024

Dental Implants Research Center, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Hezar Jerib Avenue, Isfahan, Iran.

Background: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) presents significant clinical challenges with uncertain treatment outcomes. Teriparatide, a fragment of human parathyroid hormone, shows potential in prevention strategies for BRONJ.

Objective: This study investigates the impact of a single local dose of teriparatide on BRONJ prevention in an animal model.

View Article and Find Full Text PDF

AI in oral medicine: is the future already here? A literature review.

Br Dent J

November 2024

Clinical Lecturer in Oral Medicine, Division of Dentistry, School of Medical Sciences, FBMH, University of Manchester, UK.

Objective Artificial intelligence (AI) is reshaping many healthcare disciplines, mainly with newly developed computer systems or machines that have the ability to mimic human intelligence. This paper aims to review the available evidence on the applications of AI in oral medicine. The review critically assesses current evidence, shedding light on AI's growing role in this field.

View Article and Find Full Text PDF

Targeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis.

Clin Transl Med

November 2024

Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.

Background: Bisphosphonates (BPs) are the first-line treatment to stop bone resorption in diseases, including osteoporosis, Paget's disease, multiple myeloma and bone metastases of cancer. However, BPs-related osteonecrosis of the jaw (BRONJ), characterized by local inflammation and jawbone necrosis, is a severe intractable complication. The cumulative inflammatory burden often accompanies impaired lymphatic drainage, but its specific impact on BRONJ and the underlying mechanisms remain unclear.

View Article and Find Full Text PDF

Medication-related osteonecrosis of the jaw (MRONJ) refers to the condition where the maxillary or mandibular bone becomes exposed and necrotic as a result of bisphosphonate therapy. The number of patients on bisphosphonates is increasing and so are the MRONJ cases. Since the initial data were published in the early 2000s, research into MRONJ has expanded significantly to enhance the understanding of this emerging condition.

View Article and Find Full Text PDF

Innovative Use of Limberg Flap for MRONJ Reconstruction.

J Craniofac Surg

November 2024

Department of Oral and Maxillofacial Surgery, Istanbul University, Fatih/İstanbul, Turkey.

Article Synopsis
  • Medication-related osteonecrosis of the jaw (MRONJ) is a serious issue linked to bisphosphonate use, causing bone death in the jaw area.
  • A 68-year-old woman with a cancer history faced complications after surgery for this condition, leading to the need for further reconstruction with a Limberg flap.
  • The surgery successfully healed her condition and emphasizes the need for customized treatment approaches for MRONJ, showcasing the effective use of the Limberg flap in such cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!